Inotiv, inc. announces closing of public offering and full exercise of underwriter's option to purchase additional shares

West lafayette, ind., april 23, 2021 (globe newswire) -- inotiv, inc. (nasdaq:notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced the closing of an underwritten public offering of 3,044,117 of its common shares, including 397,058 common shares sold pursuant to the full exercise by the underwriter of its option to purchase additional shares to cover over-allotments. all of the shares were sold at a price to the public of $17.00 per share. the gross proceeds to the company from this offering, before deducting the underwriting discount and offering expenses payable by the company, were approximately $51.7 million.
NOTV Ratings Summary
NOTV Quant Ranking